A Human-Safe Drug Reduces Multiple Signs of Alzheimer's in Mice
Reported byScienceAlert ↗·Sourced by Goodlede
KCL-286, a drug that has already passed Phase 1 human safety trials, reduced double-strand DNA breaks and lowered inflammation markers in Alzheimer's-model mice when administered three times weekly for three months, with researchers noting the safety data could accelerate human trials.
Mouse studies do not guarantee human efficacy; the drug is currently in early development for neurological diseases.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at ScienceAlert
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Science
Japanese Team Finds Frog Bacteria That Wipes Out Cancer Tumors With a Single Dose
Good News Network · Caution
Science
Spider-like creatures help uncover the surprising origins of fatherhood
ScienceDaily · Verified
Environment
Bacteria Turn Toxic Uranium Into a Surprisingly Stable Compound
SciTechDaily · Verified